Quantinno Capital Management LP Has $70.37 Million Position in Cardinal Health, Inc. $CAH

Quantinno Capital Management LP lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 101.6% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 333,029 shares of the company’s stock after purchasing an additional 167,804 shares during the period. Quantinno Capital Management LP’s holdings in Cardinal Health were worth $70,372,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health during the 4th quarter worth about $26,000. Bank of Jackson Hole Trust acquired a new stake in Cardinal Health in the 4th quarter valued at about $27,000. Jones Financial Companies Lllp increased its position in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Palladiem LLC bought a new position in shares of Cardinal Health in the fourth quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co acquired a new position in shares of Cardinal Health during the first quarter worth approximately $29,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 1.5%

Cardinal Health stock opened at $232.77 on Wednesday. The company has a market cap of $54.52 billion, a PE ratio of 35.59, a PEG ratio of 1.12 and a beta of 0.49. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21. The company’s 50-day moving average is $221.22 and its two-hundred day moving average is $214.82.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. Cardinal Health’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts forecast that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a dividend of $0.5158 per share. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is presently 31.50%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CAH. Morgan Stanley increased their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Mizuho boosted their price objective on shares of Cardinal Health from $235.00 to $240.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. Evercore reduced their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. William Blair initiated coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, Citigroup lifted their target price on Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research note on Friday. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $251.73.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.